Shionogi Partners with Link Medical for Cefiderocol Development in Australia and New Zealand
Japan-based Shionogi Co., Ltd. has entered into an exclusive licensing agreement with Link Medical Products...
Deals
WuXi XDC Partners with MABSOFT to Advance Innovative ADC Development
China-based WuXi XDC (HKG: 2268), a joint venture between WuXi Biologics (HKG: 2269) and WuXi...
Pfizer and Flagship Pioneering Collaborate on AI-Driven Drug Development
US pharmaceutical giant Pfizer Inc. (NYSE: PFE) has entered into a collaboration agreement with Flagship...
Nurix Therapeutics Expands Sanofi Partnership with Undisclosed TPD Program
US-based targeted protein degradation (TPD) specialist Nurix Therapeutics, Inc. (NASDAQ: NRIX) announced an expanded partnership...
Organon Acquires U.S. Rights to TOFIDENCE from Biogen
Organon (NYSE: OGN) announced today that it has acquired regulatory and commercial rights in the...
ChemPartner Plans Share Issuance to Raise Up to 316.3 Million Yuan
On April 2, 2025, ChemPartner Pharmatech (SHE: 300149) announced plans to issue shares to a...
Peijia Medical and DSM-Firmenich Collaborate on Polymer Heart Valve Innovation
Peijia Medical Technology (Suzhou) Co., Ltd. today held a strategic innovation cooperation signing ceremony and...
Medtronic Partners with Methinks AI to Enhance Stroke Care in Emerging Markets
Medtronic announced a strategic partnership with Methinks AI, a leading provider of AI-driven radiological triage...
Renji Hospital Partners with Raffles Medical Group to Boost Shanghai’s Medical Tourism
Renji Hospital, a comprehensive Class 3A hospital established in 1844 in Shanghai, has partnered with...
GE Healthcare Takes Full Ownership of Japan’s Nihon Medi-Physics
US medical device and life sciences giant GE Healthcare Technologies Inc., (NASDAQ: GEHC) announced that...
Chinese Firms Nanjing F&S and Hunan Huize Form Alliance for Full-Process Pharma Services
Chinese companies Nanjing F&S Pharmatech Co., Ltd and Hunan Huize Biopharmaceutical Technology Co., Ltd, a...
Chinese IVD Firm Annoroad Gene Targets Global Expansion with IPO
China-based Annoroad Gene Technology (Beijing) Co., Ltd. has submitted an initial public offering (IPO) filing...
Abbisko Therapeutics Secures $85M from Merck for Pimicotinib Global Rights
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) announced that its German partner Merck KGaA...
Chia Tai Tianqing Launches NPP for Urgent Cancer Treatment in Hong Kong
China-based Chia Tai Tianqing Pharmaceutical has entered into a Named Patient Program (NPP) collaboration with...
Pacific Shuanglin Bio-pharmacy Partners with XtalPi for Blood Product Innovation
China-based Pacific Shuanglin Bio-pharmacy Co., Ltd (SHE: 000403) has formed a strategic partnership with Shenzhen-based...
Apollomics Partners with LaunXP for Vebreltinib in Asian NSCLC Treatment
Apollomics Inc. announced on March 31, 2025, a strategic development and commercialization agreement with Taiwan-based...
Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone
Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration...
Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma
Japan-based Eisai (TYO: 4523) announced a strategic decision to transfer the rights of its proton...
Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy
US-based eye care firm Alcon Laboratories, Inc. has announced the acquisition of a majority stake...
TransThera and Akeso Biopharma Collaborate on HCC Study with Tinengotinib and Bispecific Antibodies
Chinese companies TransThera Sciences (Nanjing) Inc. and Akeso Biopharma (HKG: 9926) have formed a strategic...